Precision Biosciences Inc
DTILAs of the close on Sep 25, 2026
Price
$6.22
Market cap
$172M
P/E (diluted TTM)
—
A per-share figure for one of the last four quarters is not shown, so no four-quarter total is given
EPS (TTM)
—
A per-share figure for one of the last four quarters is not shown, so no four-quarter total is given
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Precision Biosciences Inc Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 8 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 5, 2026. The latest institutional report shown is dated Dec 31, 2023; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| BARCLAYS PLC | 2023-12-31 | 214,524 | Not shown | SEC filing |
| Federation des caisses Desjardins du Quebec | 2023-12-31 | 455 | Not shown | SEC filing |
| JPMORGAN CHASE & CO | 2023-12-31 | 242,815 | Not shown | SEC filing |
| HAMILTON LANE ADVISORS LLC | 2023-12-31 | 79,096 | Not shown | SEC filing |
| MORGAN STANLEY | 2023-12-31 | 334,149 | Not shown | SEC filing |
| HAMILTON LANE ADVISORS LLC | 2023-09-30 | 79,096 | Not shown | SEC filing |
| BARCLAYS PLC | 2023-09-30 | 194,208 | Not shown | SEC filing |
| Federation des caisses Desjardins du Quebec | 2023-09-30 | 455 | Not shown | SEC filing |
| BARCLAYS PLC | 2023-06-30 | 194,208 | Not shown | SEC filing |
| HAMILTON LANE ADVISORS LLC | 2023-06-30 | 79,096 | Not shown | SEC filing |
| Federation des caisses Desjardins du Quebec | 2023-06-30 | 365 | Not shown | SEC filing |
| Quent Capital, LLC | 2023-03-31 | 76 | Not shown | SEC filing |
| Federation des caisses Desjardins du Quebec | 2023-03-31 | 365 | Not shown | SEC filing |
| BARCLAYS PLC | 2023-03-31 | 194,208 | Not shown | SEC filing |
| Federation des caisses Desjardins du Quebec | 2022-12-31 | 365 | Not shown | SEC filing |
| BARCLAYS PLC | 2022-12-31 | 47,200 | Not shown | SEC filing |
| Federation des caisses Desjardins du Quebec | 2022-09-30 | 365 | Not shown | SEC filing |
| Federation des caisses Desjardins du Quebec | 2022-06-30 | 365 | Not shown | SEC filing |
| StoneX Group Inc. | 2022-06-30 | 16,283 | Not shown | SEC filing |
| Federation des caisses Desjardins du Quebec | 2022-03-31 | 365 | Not shown | SEC filing |
- Each value is checked against Precision Biosciences Inc's share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 20 rows: no share price from within three months of their report dates is on file, so they could not be checked.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- HAMILTON LANE ADVISORS LLC: 79,096 shares reported 2023-09-30; 79,096 shares reported 2023-12-31.
- Federation des caisses Desjardins du Quebec: 455 shares reported 2023-09-30; 455 shares reported 2023-12-31.
- BARCLAYS PLC: 194,208 shares reported 2023-09-30; 214,524 shares reported 2023-12-31.
- HAMILTON LANE ADVISORS LLC: 79,096 shares reported 2023-06-30; 79,096 shares reported 2023-09-30.
- Federation des caisses Desjardins du Quebec: 365 shares reported 2023-06-30; 455 shares reported 2023-09-30.
- BARCLAYS PLC: 194,208 shares reported 2023-06-30; 194,208 shares reported 2023-09-30.
- Federation des caisses Desjardins du Quebec: 365 shares reported 2023-03-31; 365 shares reported 2023-06-30.
- BARCLAYS PLC: 194,208 shares reported 2023-03-31; 194,208 shares reported 2023-06-30.
- Federation des caisses Desjardins du Quebec: 365 shares reported 2022-12-31; 365 shares reported 2023-03-31.
- BARCLAYS PLC: 47,200 shares reported 2022-12-31; 194,208 shares reported 2023-03-31.
- Federation des caisses Desjardins du Quebec: 365 shares reported 2022-09-30; 365 shares reported 2022-12-31.
- Federation des caisses Desjardins du Quebec: 365 shares reported 2022-06-30; 365 shares reported 2022-09-30.
Showing the 12 most recent filer reports.
4 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Precision Biosciences Inc's recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-01-22 · Amoroso Michael: Larger than 31 of the 34 other insider sales of Common Stock on file. SEC filing
- 2025-01-21 · Amoroso Michael: Larger than 32 of the 34 other insider sales of Common Stock on file. SEC filing
- 2024-01-22 · Amoroso Michael: Larger than all 34 other insider sales of Common Stock on file. SEC filing
- 2023-11-03 · Amoroso Michael: Larger than 33 of the 34 other insider sales of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2025-12-15–2025-12-16: 3 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
- 2025-09-22–2025-09-26: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2025-06-25–2025-06-25: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2025-03-25–2025-03-26: 3 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
- 2024-12-26–2024-12-30: 4 event(s) across 4 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-02-18 | Kelly John Alexander · Chief Financial Officer | Common Stock | S — Open market or private sale | −8,149 | 3.84 | SEC filing |
| 2026-02-18 | Scimeca Dario · General Counsel and Secretary | Common Stock | S — Open market or private sale | −4,925 | 3.84 | SEC filing |
| 2026-02-18 | SMITH J. JEFFERSON · Chief Research Officer | Common Stock | S — Open market or private sale | −4,925 | 3.84 | SEC filing |
| 2026-02-18 | Amoroso Michael · President and CEO | Common Stock | S — Open market or private sale | −20,559 | 3.84 | SEC filing |
| 2026-01-22 | Amoroso Michael · President and CEO | Common Stock | S — Open market or private sale | −34,799 | 4.17 | SEC filing |
| 2026-01-21 | Kelly John Alexander · Chief Financial Officer | Common Stock | S — Open market or private sale | −15,213 | 4.03 | SEC filing |
| 2026-01-21 | SMITH J. JEFFERSON · Chief Research Officer | Common Stock | S — Open market or private sale | −10,200 | 4.03 | SEC filing |
| 2026-01-21 | Scimeca Dario · General Counsel and Secretary | Common Stock | S — Open market or private sale | −8,854 | 4.03 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-03 | Brown Melinda · Director | Restricted Stock Units | A — Grant, award, or other acquisition | +20,979 | SEC filing |
| 2026-06-03 | Germano Geno J · Director | Restricted Stock Units | A — Grant, award, or other acquisition | +20,979 | SEC filing |
| 2026-06-03 | Frankel Stanley · Director | Restricted Stock Units | A — Grant, award, or other acquisition | +20,979 | SEC filing |
| 2026-06-03 | Buehler Kevin · Director | Restricted Stock Units | A — Grant, award, or other acquisition | +20,979 | SEC filing |
| 2026-06-03 | Pire Shari Lisa · Director | Restricted Stock Units | A — Grant, award, or other acquisition | +20,979 | SEC filing |
| 2026-06-01 | SMITH J. JEFFERSON · Chief Research Officer | Restricted Stock Units | A — Grant, award, or other acquisition | +57,389 | SEC filing |
| 2026-06-01 | Scimeca Dario · General Counsel and Secretary | Restricted Stock Units | A — Grant, award, or other acquisition | +107,604 | SEC filing |
| 2026-06-01 | Amoroso Michael · President and CEO | Restricted Stock Units | A — Grant, award, or other acquisition | +573,888 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.